Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Advanced Biosystems|May 12, 2020
Lentivirus Manufacturing Process for Primary T-Cell Biofactory ProductionHarikrishnan Radhakrishnan, Harold S Javitz, Parijat BhatnagarJournal of Controlled Release : Official Journal of the Controlled Release Society|June 16, 2025
Syngeneic CAR T cells engineered for persistent delivery of desired proteinsSherri L Newmyer, Harikrishnan Radhakrishnan, Harold S Javitz, et al.Proceedings of the National Academy of Sciences of the United States of America|September 23, 2024
Engineered CD4 T cells for in vivo delivery of therapeutic proteinsHarikrishnan Radhakrishnan, Sherri L Newmyer, Harold S Javitz, et al.Bioengineering & Translational Medicine|March 17, 2023
Electrically regulated cell-based intervention for viral infectionsSherri Newmyer, Marvin A Ssemadaali, Harikrishnan Radhakrishnan, et al.Advanced Biology|April 19, 2021
NK-Cell Biofactory as an Off-the-Shelf Cell-based Vector for Targeted In Situ Synthesis of Engineered ProteinsClaire E Repellin, Marvin A Ssemadaali, Sherri Newmyer, et al.Microbiology Spectrum|July 19, 2022
Cell-Based Platform for Antigen Testing and Its Application for SARS-CoV-2 InfectionMarvin A Ssemadaali, Sherri Newmyer, Harikrishnan Radhakrishnan, et al.Bioengineering & Translational Medicine|May 19, 2023
Genetically engineered pair of cells for serological testing and its application for SARS-CoV-2Marvin A Ssemadaali, Juan Arredondo, Elise A Buser, et al.Advanced Biosystems|April 16, 2020
Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell FunctionClaire E Repellin, Priya Ganesan, Javier F Alcudia, et al.Addiction (Abingdon, England)|May 13, 2011
The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapyHarold S Javitz, Gary E Swan, Caryn LermanAddiction (Abingdon, England)|February 11, 2012
Comparative dynamics of four smoking withdrawal symptom scalesHarold S Javitz, Caryn Lerman, Gary E SwanPageof 7